Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Josep Campistol

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Disorders

Concepts & Ideas

Anatomy

Kidney

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rovira Jordi; Arellano Edgar M; Carreras Joaquim; Campos Begoña; Vodenik Barbara; Bañón-Maneus Elisenda; Ramírez-Bajo María José; Moya-Rull Daniel; Solé-González Amanda; Hernández Astrid; Revuelta Ignacio; Quintana Luis F; Howat William J; Campistol Josep M; Diekmann Fritz
Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.
Torregrosa J-V; Bergua C; Martinez de Osaba M J; Oppenheimer F; Campistol J M
Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
Vodenik B; Rovira J; Campistol J M
Mammalian target of rapamycin and diabetes: what does the current evidence tell us?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Josep Campistol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rovira Jordi; Arellano Edgar M; Carreras Joaquim; Campos Begoña; Vodenik Barbara; Bañón-Maneus Elisenda; Ramírez-Bajo María José; Moya-Rull Daniel; Solé-González Amanda; Hernández Astrid; Revuelta Ignacio; Quintana Luis F; Howat William J; Campistol Josep M; Diekmann Fritz
Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.
Transplantation 2009;88(5):646-52.
2009: Torregrosa J-V; Bergua C; Martinez de Osaba M J; Oppenheimer F; Campistol J M
Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
Transplantation proceedings 2009;41(6):2396-8.
2009: Vodenik B; Rovira J; Campistol J M
Mammalian target of rapamycin and diabetes: what does the current evidence tell us?
Transplantation proceedings 2009;41(6 Suppl):S31-8.
2009: Campistol Josep M; Cockwell Paul; Diekmann Fritz; Donati Donato; Guirado Luis; Herlenius Gustaf; Mousa Dujanah; Pratschke Johann; San Millán Juan Carlos Ruiz
Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2009;22(7):681-7.
2009: Quintana Luis F; Campistol Josep M; Alcolea Maria P; Bañon-Maneus Elisenda; Sol-González Amandaé; Cutillas Pedro R
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.
Molecular & cellular proteomics : MCP 2009;8(7):1658-73.
2009: Arias Marta; Campistol Josep M; Vincenti Flavio
Evolving trends in induction therapy.
Transplantation reviews (Orlando, Fla.) 2009;23(2):94-102.
2009: Quintana Luís F; Solé-Gonzalez Amanda; Kalko Susana G; Bañon-Maneus Elisenda; Solé Manel; Diekmann Fritz; Gutierrez-Dalmau Alex; Abian Joaquin; Campistol Josep M
Urine proteomics to detect biomarkers for chronic allograft dysfunction.
Journal of the American Society of Nephrology : JASN 2009;20(2):428-35.
2009: Maduell Francisco; Arias Marta; Vera Manel; Fontseré Néstor; Blasco Miquel; Barros Xoana; Garro Julia; Elena Montserrat; Bergadá Eduardo; Cases Aleix; Bedini Jose Luis; Campistol Josep M
Mid-dilution hemodiafiltration: a comparison with pre- and postdilution modes using the same polyphenylene membrane.
Blood purification 2009;28(3):268-74.
2009: Santiñá M; Arrizabalaga P; Prat A; Alcaraz A; Campistol J M; Trilla A
[Institute for clinical management of nephro-urological diseases: the benefits of a quality care programme]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2009;29(2):118-22.
2009: Fontseré Néstor; Esteve Vicens; Saurina Ana; Pou Mónica; Barba Nuria; Deulofeu Ramón; Di Gregorio Silvana; del Rio Luis Miguel; Rios Jose; Torres Ferran; Maduell Franscesc; Campistol Josep M; Ramírez de Arellano Manel
The search for a new marker of renal function in older patients with chronic kidney disease stages 3-4: usefulness of cystatin C-based equations.
Nephron. Clinical practice 2009;112(3):c164-70.
2008: Campistol J M
Minimizing the risk of posttransplant malignancy.
Transplantation proceedings 2008;40(10 Suppl):S40-3.
2008: Morales Jose M; Marcén Roberto; Andrés Amado; Molina Miguel González; Castillo Domingo Del; Cabello Mercedes; Capdevila Luis; Campistol Josep M; Oppenheimer Federico; Serón Daniel; Vernet Salvador Gil; Lampreave Ildefonso; Valdés Francisco; Anaya Fernando; Escuín Fernando; Arias Manuel; Pallardó Luis; Bustamante Jesús
Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease.
Kidney international. Supplement 2008;(111):S94-9.
2008: Rovira Jordi; Marcelo Arellano Edgar; Burke James T; Brault Yves; Moya-Rull Daniel; Bañón-Maneus Elisenda; Ramírez-Bajo María J; Gutiérrez-Dalmau Alex; Revuelta Ignacio; Quintana Luis F; Campistol Josep M; Diekmann Fritz
Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(10):992-8.
2008: Fuster D; Torregrosa J-V; Setoain X; Doménech B; Campistol J M; Rubello D; Pons F
Localising imaging in secondary hyperparathyroidism.
Minerva endocrinologica 2008;33(3):203-12.
2008: Morales José M; Grinyó Josep M; Campistol Josep M; García-Martínez Javier; Arias Manuel; Paul Javier; Sánchez-Fructuoso Ana; Brunet Mercé; Granados Enrique; Munoz-Robles Jorge A
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus.
Transplantation 2008;86(4):620-2.
2008: Bergua Carlos; Torregrosa José-Vicente; Fuster David; Gutierrez-Dalmau Alex; Oppenheimer Federico; Campistol José M
Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Transplantation 2008;86(3):413-7.
2008: Maduell Francisco; Vera Manel; Arias Marta; Serra Nuria; Blasco Miguel; Bergadá Eduardo; Fontsere Nestor; Cases Aleix; Campistol Josep M
Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(1):85-92.
2008: Linares L; Cervera C; Cofán F; Lizaso D; Marco F; Ricart M J; Esforzado N; Oppenheimer F; Campistol J M; Moreno A
Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(5):1000-5.
2008: García-Ramiro S; Cofán F; Esteban P L; Riba J; Gallart X; Oppenheimer F; Campistol J M; Suso S
Total hip arthroplasty in hemodialysis and renal transplant patients.
Hip international : the journal of clinical and experimental research on hip pathology and therapy 2008;18(1):51-7.
2008: Maduell F; Vera M; Arias M; Fontseré N; Blasco M; Serra N; Bergadá E; Cases A; Campistol J M
[How much should dialysis time be increased when catheters are used?]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2008;28(6):633-6.
2007: Diekmann Fritz; Rovira Jordi; Carreras Joaquim; Arellano Edgar M; Bañón-Maneus Elisenda; Ramírez-Bajo María José; Gutiérrez-Dalmau Alex; Brunet Mercè; Campistol Josep M
Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.
Journal of the American Society of Nephrology : JASN 2007;18(10):2653-60.
2007: Lario Sergio; Bescós Mónica; Campos Begoña; Mur Cristina; Luque Pilar; Alvarez Ricardo; Campistol Josep M
Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors.
Journal of nephrology 2007;20(5):588-95.
2007: Ramos-Cebrián M; Torregrosa J-V; Gutiérrez-Dalmau A; Oppenheimer F; Campistol J-M
Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
Transplantation proceedings 2007;39(7):2251-3.
2007: Baltar J; Moran N; Ortega F; Ortega T; Rebollo P; Cofan F; Campistol J M
Erythropoietin safety and efficacy in chronic allograft nephropathy.
Transplantation proceedings 2007;39(7):2245-7.
2007: Cofan F; Arias M; Nuñez I; Cofan M; Corbella E; Rosich E; Zambón D; Ros E; Gilabert R; Oppenheimer F; Campistol J M
Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation.
Transplantation proceedings 2007;39(7):2236-8.
2007: Linares L; Cofán F; Cervera C; Ricart M J; Oppenheimer F; Campistol J M; Moreno A
Infection-related mortality in a large cohort of renal transplant recipients.
Transplantation proceedings 2007;39(7):2225-7.
2007: Linares L; Cervera C; Cofán F; Ricart M J; Esforzado N; Torregrosa V; Oppenheimer F; Campistol J M; Marco F; Moreno A
Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.
Transplantation proceedings 2007;39(7):2222-4.
2007: Cofán F; Cofan M; Rosich E; Campos B; Casals E; Zambon D; Ros E; Oppenheimer F; Campistol J M
Effect of apolipoprotein E polymorphism on renal transplantation.
Transplantation proceedings 2007;39(7):2217-8.
2007: Cofan F; Rosich E; Arias M; Torregrosa V; Oppenheimer F; Campistol J M
Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.
Transplantation proceedings 2007;39(7):2179-81.
2007: Gonzalez Molina M; Morales J M; Marcen R; Campistol J M; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
Transplantation proceedings 2007;39(7):2167-9.
2007: Ruiz J C; Campistol J M; Sanchez-Fructuoso A; Mota A; Grinyo J M; Paul J; Castro-Henriques A; Reimao-Pinto J; Garcia J; Morales J M; Granados E; Arias M
Early sirolimus use with cyclosporine elimination does not induce progressive proteinuria.
Transplantation proceedings 2007;39(7):2151-2.
2007: Saurina A; Campistol J M; Lario S; Oppenheimer F; Diekmann F
Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.
Transplantation proceedings 2007;39(7):2138-41.
2007: Arellano E M; Campistol J M; Oppenheimer F; Rovira J; Diekmann F
Sirolimus monotherapy as maintenance immunosuppression: single-center experience in 50 kidney transplant patients.
Transplantation proceedings 2007;39(7):2131-4.
2007: Friend Peter; Russ Graeme; Oberbauer Rainer; Murgia Maria G; Tufveson Gunnar; Chapman Jeremy; Blancho Gilles; Mota Alfredo; Grandaliano Giuseppe; Campistol Josep M; Brault Yves; Burke James T;
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(9):754-60.
2007: Diekmann Fritz; Campistol Josep M; Saval Núria; Gutiérrez-Dalmau Alex; Arellano Edgar M; Crespo Marta; Rossich Esther; Esforzado Núria; Cofán Federico; Ricart María José; Torregrosa José Vicente; Oppenheimer Federico
Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.
Transplantation 2007;84(3):429-32.
2007: Torregrosa José Vicente; Fuster David; Pedroso Sofía; Diekmann Fritz; Campistol Josep María; Rubí Sebastià; Oppenheimer Federico
Weekly risedronate in kidney transplant patients with osteopenia.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(8):708-11.
2007: Diekmann Fritz; Gutiérrez-Dalmau Alex; López Sonia; Cofán Federico; Esforzado Núria; Ricart María José; Rossich Esther; Saval Núria; Torregrosa José Vicente; Oppenheimer Federico; Campistol Josep M
Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2316-21.
2007: Cervera Carlos; Lozano Francisco; Saval Nuria; Gimferrer Idoia; Ibañez Ana; Suárez Belen; Linares Laura; Cofán Federico; Ricart Maria Jose; Esforzado Nuria; Marcos María Angeles; Pumarola Tomás; Oppenheimer Federico; Campistol Josep M; Moreno Asunción
The influence of innate immunity gene receptors polymorphisms in renal transplant infections.
Transplantation 2007;83(11):1493-500.
2007: Campistol Josep M; Schena Francesco P
Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22 Suppl 1():i17-22.
2007: Gutiérrez-Dalmau Alex; Campistol Josep M
The role of proliferation signal inhibitors in post-transplant malignancies.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22 Suppl 1():i11-6.
2007: Brunet Mercè; Campistol Josep M; Diekmann Fritz; Guillen David; Millán Olga
T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy.
Molecular diagnosis & therapy 2007;11(4):247-56.
2007: Gutierrez-Dalmau Alex; Campistol Josep M
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
Drugs 2007;67(8):1167-98.
2006: Marcén R; Morales J M; del Castillo D; Campistol J M; Serón D; Valdés F; Anaya F; Andrés A; Arias M; Bustamante J; Capdevila L; Escuin F; Gil-Vernet S; Gonzalez-Molina M; Lampreave I; Oppenheimer F; Pallardó L;
Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
Transplantation proceedings 2006;38(10):3530-2.
2006: Ruiz Juan Carlos; Campistol Josep M; Sánchez-Fructuoso Ana; Rivera Constantino; Oliver Juan; Ramos David; Campos Begoña; Arias Manuel; Diekmann Fritz
Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3252-7.
2006: Barrera J; Campistol J M
[Treatment of hepatitis C in hemodialysis patients and renal transplant recipients.]
Gastroenterología y hepatología 2006;29 Suppl 2():158-62.
2006: Ortín-Pérez J; Fuster D; Lomeña F; Torregrosa J V; Piera C; Rodríguez-Puig D; Duch J; Rubí S; Setoain X; Campistol J M; Pons F
[Usefulness of 111In-oxine labelled platelets in the management of febrile syndrome in dialysis patients with non-functional renal allografts]
Revista española de medicina nuclear 2006;25(5):289-93.
2006: Campistol Josep M
Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?
Nature clinical practice. Nephrology 2006;2(4):192-3.
2006: Campistol Josep M; Eris Josette; Oberbauer Rainer; Friend Peter; Hutchison Brian; Morales José M; Claesson Kerstin; Stallone Giovanni; Russ Graeme; Rostaing Lionel; Kreis Henri; Burke James T; Brault Yves; Scarola Joseph A; Neylan John F
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.
Journal of the American Society of Nephrology : JASN 2006;17(2):581-9.
2006: Saurina Anna; Campistol Josep M; Piera Carlos; Diekmann Fritz; Campos Begoña; Campos Nieves; de las Cuevas Xavier; Oppenheimer Federico
Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(2):488-93.
2006: Hernández D; Sánchez Fructuoso A; Serón D; Arias M; Campistol J M; Morales J M; Alonso A; Andrés A; del Castillo D; Gentil M A; González-Molina M; González Posada J M; Moreso F; Oppenheimer F; Pallardó L M; Solá R;
[Chronic transplant nephropathy]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2006;26 Suppl 1():1-38.
2005: Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial M C; Iranzo P; Torregrosa J V; Oppenheimer F; Campistol J M
Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
Transplantation proceedings 2005;37(9):3836-8.
2005: Ruiz J C; Diekmann F; Campistol J M; Sanchez-Fructuoso A; Rivera C; Oliver J; Fernandez-Fresnedo G; Arias M
Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study.
Transplantation proceedings 2005;37(9):3833-5.
2005: Cofan M; Cofan F; Campos B; Guerra R; Campistol J M; Oppenheimer F
Effect of apolipoprotein B polymorphism in kidney transplantation.
Transplantation proceedings 2005;37(9):3794-5.
2005: Cofan F; Cofan M; Campos B; Guerra R; Campistol J-M; Oppenheimer F
Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
Transplantation proceedings 2005;37(9):3791-3.
2005: Diekmann Fritz; Gutierrez-Dalmau Alex; Torregrosa José Vicente; Oppenheimer Federico; Campistol Josep M
Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation--a pilot experience.
Transplantation 2005;80(9):1344-8.
2005: Campistol Josep M; Holt David W; Epstein Solomon; Gioud-Paquet Martine; Rutault Karine; Burke James T;
Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(9):1028-35.
2005: Gutiérrez-Dalmau Alex; Campistol Josep M
Kaposi's sarcoma after renal transplantation.
The New England journal of medicine 2005;353(8):846-7; author reply 846-7.
2005: Morales J M; Campistol J M; Kreis H; Mourad G; Eris J; Schena F P; Grinyo J M; Nanni G; Andres A; Castaing N; Brault Y; Burke J T
Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
Transplantation proceedings 2005;37(2):693-6.
2005: Oberbauer Rainer; Segoloni Giuseppe; Campistol Josep M; Kreis Henri; Mota Alfredo; Lawen Joseph; Russ Graeme; Grinyó Josep M; Stallone Giovanni; Hartmann Anders; Pinto Jose R; Chapman Jeremy; Burke James T; Brault Yves; Neylan John F;
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(1):22-8.
2004: Grinyó Josep M; Cruzado Josep M; Millán Olga; Caldés Anna; Sabaté Isabel; Gil-Vernet Salvador; Serón Daniel; Brunet Mercé; Campistol Josep M; Torras Joan; Martorell Jaume
Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts.
Transplantation 2004;78(9):1400-3.
2004: Ruiz Juan C; Campistol Josep M; Grinyó Josep M; Mota Alfredo; Prats Dolores; Gutiérrez Jose A; Henriques Antonio C; Pinto Jose R; García Javier; Morales Jose M; Gómez Jose M; Arias Manuel
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Transplantation 2004;78(9):1312-8.
2004: Grinyo Josep María; Campistol José María; Paul Javier; García-Martínez Javier; Morales José María; Prats Dolores; Arias Manuel; Brunet Mercedes; Cabrera José; Granados Enrique
Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(8):1308-14.
2004: Rebollo Paolo; Baltar José M; Campistol Josep M; Ortega Teresa; Ortega Francisco
Quality of life of patients with chronic renal allograft rejection and anemia.
Journal of nephrology 2004;17(4):531-6.
2004: Campistol Josep M; Romero Rafael; Paul Javier; Gutiérrez-Dalmau Alex
Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 3():iii62-6.
2004: Mota Alfredo; Arias Manuel; Taskinen Eero I; Paavonen Timo; Brault Yves; Legendre Christophe; Claesson Kerstin; Castagneto Marco; Campistol Josep M; Hutchison Brian; Burke James T; Yilmaz Sedar; Häyry Pekka; Neylan John F;
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(6):953-61.
2004: Brunet M; Millán O; Jiménez O; Campistol J M; Vidal E; Rojo I; Oppenheimer F; Fortuna V; Martorell J
New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
Transplantation proceedings 2004;36(2 Suppl):437S-441S.
2004: Coll E; Crespo M; Solé M; Campistol J M; Cofàn F; Esforzado N; Ricart M J; Torregrosa J V; Oppenheimer F
Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.
Transplantation proceedings 2004;36(2 Suppl):114S-116S.
2004: Campistol Josep M; Gutierrez-Dalmau Alex; Torregrosa J Vicente
Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.
Transplantation 2004;77(5):760-2.
2004: Kreis Henri; Oberbauer Rainer; Campistol Josep M; Mathew Timothy; Daloze Pierre; Schena Francesco P; Burke James T; Brault Yves; Gioud-Paquet Martine; Scarola Joseph A; Neylan John F;
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
Journal of the American Society of Nephrology : JASN 2004;15(3):809-17.
2003: Millán Olga; Brunet Mercè; Campistol Josep M; Faura Ana; Rojo Isabel; Vidal Elena; Jiménez Olga; Vives Jordi; Oppenheimer Federic; Martorell Jaume
Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil.
Clinical chemistry 2003;49(11):1891-9.
2003: Cofan M; Cofan F; Campos B; Casals E; Zambon D; Ros E; Campistol J M; Oppenheimer F
Effect of apolipoprotein polymorphisms in renal transplant recipients.
Transplantation proceedings 2003;35(5):1725-6.
2003: Jiménez O; Campistol J M; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
Transplantation proceedings 2003;35(5):1686-8.
2003: Ruiz J C; Campistol J M; Mota A; Prats D; Gutiérrez J A; Castro A; García J; Morales J M; Grynió J M; Gómez J M; Arias M
Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Transplantation proceedings 2003;35(5):1669-70.
2003: Xaubet Antoni; Marin-Arguedas Alejandra; Lario Sergio; Ancochea Julio; Morell Ferran; Ruiz-Manzano Juan; Rodriguez-Becerra Eulogio; Rodriguez-Arias Jose M; Inigo Pablo; Sanz Sergi; Campistol Josep M; Mullol Joaquim; Picado Cesar
Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2003;168(4):431-5.
2003: Iñigo P; Lario S; Campistol J M; Bescós M; Campos B; Oppenheimer F
[Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23(4):312-20.
2003: Brunet M; Campistol J M; Millán O; Vidal E; Esforzado N; Rojo I; Jiménez O; Oppenheimer F; Corbella J; Martorell J
Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C(2).
International immunopharmacology 2003;3(7):987-99.
2003: Lario Sergio; Mendes Diogo; Bescós Mónica; Iñigo Pablo; Campos Begoña; Alvarez Ricardo; Alcaraz Antonio; Rivera-Fillat Francisca; Campistol Josep M
Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Transplantation 2003;75(10):1647-54.
2003: Charpentier B; Groth C G; Bäckman L; Morales J-M; Calne R; Kreis H; Lang P; Touraine J-L; Claesson K; Campistol J M; Durand D; Wramner L; Brattström C;
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Transplantation proceedings 2003;35(3 Suppl):58S-61S.
2003: Iñigo Pablo; Campistol Josep M; Saracho Ramón; Del Castillo Domingo; Anaya Fernando; Esforzado Nuria; Navarro Maria D; Oppenheimer Federico
Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study.
Nephron. Clinical practice 2003;95(3):c84-90.
2003: Crespo M; Campistol J M
[Endothelial dysfunction in renal transplantation]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23 Suppl 4():52-8.
2003: Lario S; Bescós M; Campistol J M
[Applications of molecular biology to renal transplant]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23(1):15-26.
2002: Morales José M; Campistol Josep M; Dominguez-Gil Beatriz
Hepatitis C virus infection and kidney transplantation.
Seminars in nephrology 2002;22(4):365-74.
2002: Campistol Josep M; Esforzado Nuria; Morales José M
Hepatitis C virus-positive patients on the waiting list for transplantation.
Seminars in nephrology 2002;22(4):361-4.
2002: Morales José M; Wramner Lars; Kreis Henri; Durand Dominique; Campistol Josep M; Andres Amado; Arenas Joaquin; Nègre Eric; Burke James T; Groth Carl G;
Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(5):436-42.
2002: Miró Oscar; Marrades Ramon M; Roca Josep; Sala Ernest; Masanés Ferran; Campistol Josep M; Torregrosa Josep V; Casademont Jordi; Wagner Peter D; Cardellach Francesc
Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(5):1025-31.
2002: Violan M A; Pomes T; Maldonado S; Roura G; De la Fuente I; Verdaguer T; Lloret R; Torregrosa J V; Campistol J M
Exercise capacity in hemodialysis and renal transplant patients.
Transplantation proceedings 2002;34(1):417-8.
2002: Cofan F; Gilabert R; Nunez I; Zambon D; Ros E; Casals E; Cofan M; Muray S; Campistol J M; Bru C; Oppenheimer F
Influence of renal posttransplantation dyslipidemia on the degree and severity of carotid and femoral atherosclerosis evaluated by B-mode ultrasound.
Transplantation proceedings 2002;34(1):412-4.
2002: Cofan F; Zambon D; Laguna J C; Casals E; Ros E; Cofan M; Campistol J M; Oppenheimer F
Pravastatin improves low-density lipoprotein oxidation in renal transplantation.
Transplantation proceedings 2002;34(1):389-91.
2002: Cofan F; Gilabert R; Zambon D; Nunez I; Ros E; Cofan M; Campistol J M; Bru C; Oppenheimer F
Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients.
Transplantation proceedings 2002;34(1):384-8.
2002: Cofan F; Zambon D; Laguna J C; Ros E; Casals E; Cofan M; Campistol J M; Oppenheimer F
Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.
Transplantation proceedings 2002;34(1):377-8.
2002: Cofan F; Zambon D; Laguna J C; Ros E; Casals E; Cofan M; Campistol J M; Oppenheimer F
Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine.
Transplantation proceedings 2002;34(1):374-6.
2002: Ruiz J C; Campistol J M; Mota A; Prats D; Gutiérrez A; Castro A; Pinto J R; García J; Morales J M; Grinyo J M; Arias M
Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant.
Transplantation proceedings 2002;34(1):92-3.
2002: Pérez-Valentín M A; Cofán F; Solé M; Llach J; Esforzado N; Campistol J M; Oppenheimer F
[Atypical cytomegalovirus in renal transplantation: a new form of presentation]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22(4):381-5.
2002: Campistol J M
[Cardiovascular risk in patients with renal transplantation]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22 Suppl 4():7-11.
2002: Morales J M; González Molina M; Campistol J M; del Castillo D; Anaya F; Oppenheimer F; Gil Vernet J M; Grinyo J M; Capdevila L; Lampreave I; Valdés F; Marcén R; Escuín F; Andrés A; Arias M; Pallardó L
[Prevention of cardiovascular risk in renal transplantation. Consensus document]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22 Suppl 4():35-56.
2002: Campistol J M; Esforzado N; Morales J M; Barrera J M
[Kidney transplantation in patients positive for hepatitis C virus]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22 Suppl 5():62-6.
2002: Campistol J M
[Cardiovascular risk in the kidney transplant patient]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22 Suppl 1():75-9.
2001: Wagner P D; Masanés F; Wagner H; Sala E; Miró O; Campistol J M; Marrades R M; Casademont J; Torregrosa V; Roca J
Muscle angiogenic growth factor gene responses to exercise in chronic renal failure.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;281(2):R539-46.
2001: Campistol J M; Grinyó J M
Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.
Transplantation 2001;71(11 Suppl):SS42-51.
2001: Iñigo P; Campistol J M; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Journal of the American Society of Nephrology : JASN 2001;12(4):822-7.
2001: Sala E; Noyszewski E A; Campistol J M; Marrades R M; Dreha S; Torregrossa J V; Beers J S; Wagner P D; Roca J
Impaired muscle oxygen transfer in patients with chronic renal failure.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(4):R1240-8.
2001: Campistol J M; Garcia S; Combalia A; Solé M; Ramón R
Symptomatic destructive spondyloarthropathy secondary to beta2-microglobulin amyloidosis. Report of four cases.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2001;8(1):65-70.
2001: Campistol J M
Dialysis-related amyloidosis after renal transplantation.
Seminars in dialysis 2001;14(2):99-102.
2001: Morales J M; Campistol J M; Andres A; Dominguez-Gil B; Esforzado N; Oppenheimer F; Rodicio J L
Use of kidneys from anti-HCV positive donors.
Transplantation proceedings 2001;33(1-2):1776-7.
2001: Domínguez-Gil B; Esforzado N; Muñoz M A; Andrés A; Rodicio J L; Bruguera M; Oppenheimer F; Campistol J M; Morales J M
[Renal transplantation using kidneys from donors with hepatitis C virus positive serology]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2001;21 Suppl 4():119-23.
2001: Esmatjes E; Flores L; Iñigo P; Lario S; Ruilope L M; Campistol J M
Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 1():90-3.
2000: Saurina A; Vera M; Pou M; López Pedret J; Darnell A; Campistol J M; Cases A
[Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2000;20(6):554-8.
2000: Morales J M; Campistol J M
Transplantation in the patient with hepatitis C.
Journal of the American Society of Nephrology : JASN 2000;11(7):1343-53.
2000: Esforzado N; Morales J M; Campistol J M
[Glomerulonephritis associated with chronic hepatitis C virus infection]
Gastroenterología y hepatología 2000;23(6):300-6.
2000: Morales J M; Campistol J M; Andrés A; Herrero J C
Immunosuppression in older renal transplant patients.
Drugs & aging 2000;16(4):279-87.
2000: Kreis H; Cisterne J M; Land W; Wramner L; Squifflet J P; Abramowicz D; Campistol J M; Morales J M; Grinyo J M; Mourad G; Berthoux F C; Brattström C; Lebranchu Y; Vialtel P
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
Transplantation 2000;69(7):1252-60.
2000: Morales J M; Campistol J M; Andrés A; Dominguez-Gil B; Esforzado N; Muñoz M A; Bruguera M; Oppenheimer F; Rodicio J L
Policies concerning the use of kidneys from donors infected with hepatitis C virus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 8():71-3.
2000: Campistol J M; Esforzdo N; Barrera J M; Morales J M; Oppenheimer F
Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 8():68-70.
2000: García S; Cofán F; Combalia A; Campistol J M; Oppenheimer F; Ramón R
Compression of the ulnar nerve in Guyon's canal by uremic tumoral calcinosis.
Archives of orthopaedic and trauma surgery 2000;120(3-4):228-30.
1999: Campistol J M; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva J A; Costa J; Barrera J M; Bruguera M
Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(11):2704-9.
1999: Moreno A; Torregrosa J V; Pons F; Campistol J M; Martínez de Osaba M J; Oppenheimer F
Bone mineral density after renal transplantation: long-term follow-up.
Transplantation proceedings 1999;31(6):2322-3.
1999: Iñigo P; Torregrosa J V; Campistol J M; Oppenheimer F
Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis.
Transplantation proceedings 1999;31(6):2321.
1999: Torregrosa J V; Poch E; Oriola J; Campistol J M; Cofan F; Iñigo P; Oppenheimer F
Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene.
Transplantation proceedings 1999;31(6):2319-20.
1999: Iñigo P; Palacín A; Campistol J M; Clesca P H; Vilardell J; Solé M; Oppenheimer F
Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor beta-1.
Transplantation proceedings 1999;31(6):2309-10.
1999: Campistol J M; Mazuecos A; Segura J; Osuna A; Herrero J C; Andres A; Oppenheimer F; Gomez de la Camara A; Martinez M A; Morales J M
Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.
Transplantation proceedings 1999;31(6):2267-9.
1999: Campistol J M; Iñigo P; Jimenez W; Lario S; Clesca P H; Oppenheimer F; Rivera F
Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Kidney international 1999;56(2):714-9.
1999: Lario S; Iñigo P; Campistol J M; Poch E; Rivera F; Oppenheimer F
Restriction enzyme-based method for transforming growth factor-beta(1) genotyping: nonisotopic detection of polymorphisms in codons 10 and 25 and the 5'-flanking region.
Clinical chemistry 1999;45(8 Pt 1):1290-2.
1999: Groth C G; Bäckman L; Morales J M; Calne R; Kreis H; Lang P; Touraine J L; Claesson K; Campistol J M; Durand D; Wramner L; Brattström C; Charpentier B
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.
Transplantation 1999;67(7):1036-42.
1999: García S; Cofán F; Combalia A; Casas A; Campistol J M; Oppenheimer F
[Compression of the sciatic nerve in uremic tumor calcinosis]
Neurología (Barcelona, Spain) 1999;14(2):86-9.
1999: Cofan F; García S; Combalia A; Campistol J M; Oppenheimer F; Ramón R
Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.
The Journal of rheumatology 1999;26(2):379-85.
1999: Campistol J M; Torregrosa J V; Ponz E; Fenollosa B
Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
Contributions to nephrology 1999;125():76-85.
1998: del Castillo D; Campistol J M; Guirado L; Capdevilla L; Martínez J G; Pereira P; Bravo J; Pérez R
Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients.
Kidney international. Supplement 1998;68():S135-9.
1997: Cofán F; García S; Campistol J M; Combalia A; Oppenheimer F; Ramón R
Ulnar nerve compression--a case of giant uremic tumoral calcinosis.
Acta orthopaedica Scandinavica 1997;68(3):302-4.
1997: Morales J M; Pascual-Capdevila J; Campistol J M; Fernandez-Zatarain G; Muñoz M A; Andres A; Praga M; Martinez M A; Usera G; Fuertes A; Oppenheimer F; Artal P; Darnell A; Rodicio J L
Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients.
Transplantation 1997;63(11):1634-9.
1997: Marrades R M; Diaz O; Roca J; Campistol J M; Torregrosa J V; Barberà J A; Cobos A; Félez M A; Rodriguez-Roisin R
Adjustment of DLCO for hemoglobin concentration.
American journal of respiratory and critical care medicine 1997;155(1):236-41.
1996: Marrades R M; Alonso J; Roca J; González de Suso J M; Campistol J M; Barberá J A; Diaz O; Torregrosa J V; Masclans J R; Rodríguez-Roisin R; Wagner P D
Cellular bioenergetics after erythropoietin therapy in chronic renal failure.
The Journal of clinical investigation 1996;97(9):2101-10.
1996: Marrades R M; Roca J; Campistol J M; Diaz O; Barberá J A; Torregrosa J V; Masclans J R; Cobos A; Rodríguez-Roisin R; Wagner P D
Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.
The Journal of clinical investigation 1996;97(9):2092-100.
1996: Oppenheimer F; Cofán F; Lomeña F; Setoain F J; Vilardell J; Ricart M J; Campistol J M; Carretero P
MAG-3 scintigraphy in renal transplantation from non-heart-beating donors.
Transplantation proceedings 1996;28(1):207-8.
1996: Cofán F; Ricart M J; Oppenheimer F; Vilardell J; Campistol J M; Astudillo E; Fernández-Cruz L; Carretero P
Study of kidney rejection following simultaneous kidney-pancreas transplantation.
Nephron 1996;74(1):58-63.
1996: Torregrosa J V; Campistol J M; Más M; Montesinos M; Martinez de Osaba M J
Usefulness and pharmacokinetics of subcutaneous calcitriol in the treatment of secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 3():54-7.
1996: Torregrosa J V; Campistol J M; Fenollosa B; Montesinos M; Romar A; Martinez de Osaba M J
Role of secondary hyperparathyroidism in the development of post-transplant acute tubular necrosis.
Nephron 1996;73(1):67-72.
1995: Cofán F; Oppenheimer F; Campistol J M; Flores R; Vilardell J; Ricart M J; Carretero P
Advanced age donors in the evolution of renal transplantation.
Transplantation proceedings 1995;27(4):2248-9.
1995: Campistol J M; Cofan F; Díaz Ricart M; Tassies D; Cases A; Torregrosa J V; Ricart J; Vilardell J; Oppenheimer F; Escolar G
Correction of uremic platelet dysfunction after renal transplantation.
Transplantation proceedings 1995;27(4):2244-5.
1995: Ricart M J; Bacqué M C; Esmatjes E; Oppenheimer F; Vilardell J; Campistol J M; Carretero P; Fernández-Cruz L
Influence of simultaneous pancreas and kidney transplantation on renal graft survival.
Transplantation proceedings 1995;27(4):2237-8.
1995: Oppenheimer F; Flores R; Cofán F; Campistol J M; Ochs J; Ricart M J; Vilardell J; Torregrosa J V; Darnell A; Carretero P
Treatment with angiotensin-converting enzyme inhibitors in renal transplantation with proteinuria.
Transplantation proceedings 1995;27(4):2235-6.
1995: Torregrosa J V; Campistol J M; Montesinos M; Fenollosa B; Pons F; Martinez de Osaba M J; Oppenheimer F
Factors involved in the loss of bone mineral density after renal transplantation.
Transplantation proceedings 1995;27(4):2224-5.
1995: Mallofré C; Almirall J; Campistol J M; Muntané J; Cardesa A
DNA flow cytometric analysis in renal neoplasms associated with acquired renal cystic disease.
Histopathology 1995;26(2):131-6.
1995: Morales J M; Campistol J M; Castellano G; Andres A; Colina F; Fuertes A; Ercilla G; Bruguera M; Andreu J; Carretero P
Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.
Kidney international 1995;47(1):236-40.
1995: Torregrosa J V; Campistol J M; Montesinos M; Pons F; Martinez de Osaba M J
Evolution of bone mineral density after renal transplantation: related factors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10 Suppl 6():111-3.
1995: Cofán F; Parra E; Solé M; Ricart M J; Oppenheimer F; Campistol J M; Vilardell J; Carretero P
Renal oncocytoma in a long-term renal-transplant recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(4):560-2.
1994: Oppenheimer F; Hotter G; Bulbena O; Roselló-Catafau J; Gelpí E; Vilardell J; Ricart M J; Campistol J M; Fernández-Cruz L; Carretero P
Urinary prostanoids excretion in kidney transplantation: its relationship to acute rejection and cyclosporine-induced nephrotoxicity.
Transplantation proceedings 1994;26(5):2606-7.
1994: Oppenheimer F; Cofán F; Flores R; Pais B; Ochs J; Ricart M J; Vilardell J; Campistol J M; Torregrosa J V
Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
Transplantation proceedings 1994;26(5):2516-7.
1994: Torregrosa J V; Campistol J M; Montesinos M; Rogada A G; Oppenheimer F; Andreu J
Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Transplantation 1994;58(3):311-4.
1994: Torregrosa J V; Bassa P; Lomeña F J; Campistol J M; Oppenheimer F; Almirall J; Muxí A; Andreu J; Setoain J
The usefulness of 111In-labeled platelet scintigraphy in the diagnosis of patients with febrile syndrome and a nonfunctioning renal graft.
Transplantation 1994;57(12):1732-5.
1994: Andreu J; Campistol J M; Oppenheimer F; Torregrosa V; Ricart M J; Vilardell J; Carretero P
Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience.
Transplantation proceedings 1994;26(1):337-40.
1993: Campistol J M; Molina R; Bernard D B; Rodriguez R; Mirapeix E; Munoz-Gomez J M; Revert L
Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(5):691-9.
1993: Torregrosa J V; Ricart M J; Montesinos M; Campistol J M; Moreno A; Claramonte X; Andreu J; Carretero P
Visceral leishmaniasis-like cause of unexplained fever in a reno-pancreatic graft recipient.
Nephron 1993;65(2):318-9.
1993: Almirall J; Campistol J M; Sole M; Andreu J; Revert L
Blood and graft eosinophilia as a rejection index in kidney transplant.
Nephron 1993;65(2):304-9.
1992: Campistol J M; Solé M; Bombi J A; Rodriguez R; Mirapeix E; Muñoz-Gomez J; Revert O W
In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture.
The American journal of pathology 1992;141(1):241-7.
1992: Mallofré C; Almirall J; Campistol J M; Andreu J; Cardesa A; Revert L
Acquired renal cystic disease in HD: a study of 82 nephrectomies in young patients.
Clinical nephrology 1992;37(6):297-302.
1992: Almirall J; Sole M; Campistol J M; Muntane J; Bru C; Oppenheimer F; Andreu J; Revert L
Clinical usefulness of conventional fine needle aspiration cytology in kidney transplantation--influence of different immunosuppressive protocols.
Transplantation proceedings 1992;24(1):71-2.
1992: Almirall J; Sole M; Campistol J M; Bru C; Oppenheimer F; Andreu J; Revert L
HLA-DR expression on tubular cells in kidney transplants.
Transplantation proceedings 1992;24(1):69-70.
1992: Almirall J; Sole M; Campistol J M; Villamor N; Oppenheimer F; Andreu J; Revert L
Lymphocyte activation and proliferation markers in the material obtained by fine needle aspiration cytology.
Transplantation proceedings 1992;24(1):67-8.
1992: Oppenheimer F; Alcaraz A; Mañalich M; Ricart M J; Vilardell J; Campistol J M; Andreu J; Talbot-Wright R; Fernandez-Cruz L
Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation.
Transplantation proceedings 1992;24(1):50-1.
1992: Andreu J; de la Torre M; Oppenheimer F; Campistol J M; Ricart M J; Vilardell J; Talbot R; Carretero P
Renal transplantation in elderly recipients.
Transplantation proceedings 1992;24(1):120-1.
1992: Campistol J M; Ponz E; Muñoz-Gómez J; Oppenheimer F; Ricard M J; Vilardell J; Andreu J
Renal transplantation for dialysis amyloidosis.
Transplantation proceedings 1992;24(1):118-9.
1991: Muñoz-Gomez J; Collado A; Gratacós J; Campistol J M; Lomeña F; Llena J; Andreu J
Reflex sympathetic dystrophy syndrome of the lower limbs in renal transplant patients treated with cyclosporin A.
Arthritis and rheumatism 1991;34(5):625-30.
1991: Gilabert R; Campistol J M; Bru C; Vilardell J; Bianchi L; Andreu J
Utility of pulsed Doppler in the diagnosis and follow-up of acute vascular graft rejection treated with OKT3 monoclonal antibody or antilymphocyte serum.
Transplantation 1991;51(3):614-8.
1991: Campistol J M; Oppenheimer F; Vilardell J; Ricart M J; Alcaraz A; Ponz E; Andreu J
Interaction between ciclosporin and diltiazem in renal transplant patients.
Nephron 1991;57(2):241-2.
1991: Campistol J M; Molina R; Rodriguez R; Mirapeix E; Muñoz-Gomez J; Revert L
Dialysis membranes inhibit synthesis and release of beta 2-microglobulin in lymphocyte culture.
Nephron 1991;59(4):691-2.
1990: Campistol J M; Almirall J; Oppenheimer F; Ricart M J; Vilardell J; Andreu J
Glomerular disease after kidney transplantation.
Transplantation proceedings 1990;22(5):2275-6.
1990: Andreu J; Campistol J M; Oppenheimer F; Ricart M J; Vilardell J; Carretero P
Monotherapy with cyclosporine in kidney transplantation.
Transplantation proceedings 1990;22(5):2270-1.
1990: Ponz E; Piera C; Campistol J M; Lomeña F; Pavía A; Herranz R; Muñoz Gómez J; Setoain J; Revert L
[The gammagraphic diagnosis of dialysis-associated amyloidosis with beta 2-microglobulin-I-131. Preliminary results]
Medicina clínica 1990;95(14):538-9.
1990: Campistol J M; Muñoz-Gomez J; Solé M; Oppenheimer F; Vilardell J; Andreu J
Results of renal transplantation for dialysis arthropathy.
Transplantation proceedings 1990;22(4):1416.
1990: Almirall J; Ricart M J; Campistol J M; Vilardell J; Openheimer F; Andreu J
Renal cell carcinoma and acquired cystic kidney disease after renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1990;3(1):49.
1990: Campistol J M; Solé M; Muñoz-Gómez J; Riba J; Ramón R; Revert L
Pathological fractures in patients who have amyloidosis associated with dialysis. A report of five cases.
The Journal of bone and joint surgery. American volume 1990;72(4):568-74.
1990: Campistol J M; Solé M; Muñoz-Gomez J; Lopez-Pedret J; Revert L
Systemic involvement of dialysis-amyloidosis.
American journal of nephrology 1990;10(5):389-96.
1989: Rello J; Gatell J M; Almirall J; Campistol J M; Gonzalez J; Puig de la Bellacasa J
Evaluation of culture techniques for identification of catheter-related infection in hemodialysis patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):620-2.
1989: Campistol J M; Maragall D; Andreu J
Interaction between ciclosporin A and Sintrom.
Nephron 1989;53(3):291-2.
1989: Campistol J M; Cases A; Botey A; Revert A
Acute aluminum encephalopathy in an uremic patient.
Nephron 1989;51(1):103-6.
1989: Campistol J M; Abad C; Torras A; Revert L
Salvage of upper arm access graft in the presence of symptomatic subclavian vein thrombosis.
Nephron 1989;51(4):551-2.
1989: Campistol J M; Almirall J; Martin E; Torras A; Revert L
Calcium-carbonate-induced calciphylaxis.
Nephron 1989;51(4):549-50.
1989: Solé M; Cardesa A; Palacín A; Muñoz-Gómez J; Campistol J M
Morphological and immunohistochemical findings in dialysis-related amyloidosis. An analysis of 16 cases.
Applied pathology 1989;7(6):350-60.
1989: Almirall J; Gonzalez J; Rello J; Campistol J M; Montoliu J; Puig de la Bellacasa J; Revert L; Gatell J M
Infection of hemodialysis catheters: incidence and mechanisms.
American journal of nephrology 1989;9(6):454-9.
1989: Campistol J M; Almirall J; Montoliu J; Revert L
Electrographic alterations induced by hyperkalaemia simulating acute myocardial infarction.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1989;4(3):233-5.
1988: Almirall J; Campistol J M; Torras A; López-Pedret J; Revert L
[Efficacy of calcium carbonate as a phosphorus-chelating agent in hemodialysis patients]
Medicina clínica 1988;91(11):409-12.
1988: Campistol J M; Agustí C; Torras A; Campo E; Abad C; Revert L
Renal hemangioma and renal artery aneurysm in the Klippel-Trenaunay syndrome.
The Journal of urology 1988;140(1):134-6.
1988: Cases A; Kelly J; Sabater J; Campistol J M; Torras A; Montoliu J; López I; Revert L
Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine.
Clinical nephrology 1988;29(4):176-8.
1988: Campistol J M; Torras A; Lopez-Pedret J
Systemic character and visceral involvement of dialysis amyloidosis.
Clinical nephrology 1988;29(2):105-6.
1988: Cases A; Campistol J M; Sabater M; López-Pedret J; Revert L
Desferrioxamine-induced acute neurosensorial deafness.
Nephron 1988;48(4):326.
1988: Campistol J M; Solé M; Ferrando J; Palou J; Muñoz-Gómez J; López-Pedret J; Revert L
Negativeness of skin biopsy in dialysis amyloidosis.
Nephron 1988;48(3):259-60.
1988: Cases A; Campistol J M; Abad C; Botey A; Torras A; Revert L
Reversal of renal failure after revascularization in atheromatous renovascular disease. Report of two cases.
American journal of nephrology 1988;8(6):479-82.
1988: Campistol J M; Montoliu J; Soler-Amigó J; Darnell A; Revert L
Renal amyloidosis with nephrotic syndrome in a Spanish subcutaneous heroin abuser.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(4):471-3.
1987: Campistol J M; Torras A; Lopez-Pedret J
Systemic character and visceral involvement of dialysis amyloidosis.
Clinical nephrology 1987;28(5):261.
1987: Campistol J M; Cases A; López-Pedret J; Revert L
Thoracic duct injury: an unusual complication following subclavian catheterization for hemodialysis.
Nephron 1987;46(4):390-1.
1987: Campistol J M; Cases A; Torras A; Soler M; Muñoz-Gómez J; Montoliu J; López-Pedret J; Revert L
Visceral involvement of dialysis amyloidosis.
American journal of nephrology 1987;7(5):390-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Josep Campistol

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Disorders

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Josep Campistol (preview)

All Publications